CVE-2026-6371

MEDIUMCVSS 4.8/10EPSS 0.15%

Last modified

CVE-2026-6371 is a medium-severity vulnerability rated 4.8/10 on the CVSS scale. Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in Limatek System Inc. LimRAD NAC allows Stored XSS. This issue affects LimRAD NAC: before 5.5.7.3.9.. EPSS estimates a 0.15% chance of exploitation in the next 30 days.

Description

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in Limatek System Inc. LimRAD NAC allows Stored XSS. This issue affects LimRAD NAC: before 5.5.7.3.9.

Metrics

CVSS 3.1
4.8/10

CVSS:3.1/AV:A/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N

EPSS Probability
0.15%

4.5th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

Source: CNA advisory (CVE.org). NVD analysis pending.

VendorProductVersions
Limatek System Inc.LimRAD NAC<= 08072026

References

Timeline

Published
Last Modified
Status
Deferred

Frequently Asked Questions

What is CVE-2026-6371?
Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in Limatek System Inc. LimRAD NAC allows Stored XSS. This issue affects LimRAD NAC: before 5.5.7.3.9.
How severe is CVE-2026-6371?
CVE-2026-6371 has a CVSS score of 4.8/10 (MEDIUM severity). The EPSS model estimates a 0.15% probability of exploitation in the next 30 days.
How do I fix CVE-2026-6371?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-6371?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST